Search

Now showing items 1-2 of 2

Pregnancy rates among female participants in phase I and phase IIA AIDS vaccine clinical trials in Kenya

Jaoko, Walter; Ogutu, H.; Wakasiaka, S; Malogo, R.; Ndambuki, R; Nyange, J; Omosa-Manyonyi, G.; Fast, P; Schmidt, C; Verlinde, C; Smith, C; Bhatt, K.M; Ndinya-Achola, JO; Anzala, O (2009-09)

Background: Female participants in AIDS candidate vaccine clinical trials must agree to use effective contraception to be enrolled into the studies, and for a specified period after vaccination, since the candidate vaccines’ ...

Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency

John, G; Nduati, RW; Mbori-Ngacha, DA; Overbaugh, J; Welch, M; Richardson, B; Ndinya-Achola, JO; Bwayo, JJ; Krieger, J; Onyango, F; Kreiss, J K (1997-01)

The presence of human immunodeficiency virus type 1 (HIV-1) in genital secretions may be a determinant of vertical HIV-1 transmission. Cervical and vaginal secretions from HIV-1–seropositive pregnant women were evaluated ...